The Division of Genomic Epidemiology and Clinical Outcomes brings together a core group of 
faculty with expertise in outcomes research as it applies to the health care system. The division 
houses nationally known experts in infectious diseases and genomic epidemiology.

Faculty members have expertise in clinical and health care epidemiology, quality improvement 
research, technology assessment including artificial intelligence, clinical decision-making, 
healthcare administration, health services, policy and economics.

Mission Statement

The Division of Genomic Epidemiology and Clinical Outcomes accelerates the future of patient and population health by integrating cutting-edge genomic science, clinical outcomes research, and artificial intelligence. Through cross-disciplinary collaboration among experts in infectious diseases, epidemiology, and health systems at the University of Maryland Medical Center, the VA Maryland Healthcare System, and the Institute for Genome Sciences, we generate breakthrough insights that elevate care quality, enhance clinical decision-making, and cultivate the next generation of researchers.

Our division is involved in research, teaching, and practice:

• Examining how artificial intelligence can be used to reduce diagnostic error and improve
  patient outcomes
• Clinical AI regulation (FDA, legal, and anti-discrimination law)
• Leveraging large real-world datasets to answer meaningful epidemiologic questions
• Diagnostic stewardship
• Antimicrobial stewardship
• Surveillance and prevention of healthcare associated infections
• Machine learning and predictive modeling for rare diseases
• Traumatic brain injury (TBI) and sleep disorders in older adults
• Addressing vulnerabilities within global health security, specifically in infection prevention 
  infrastructure and biodefense